Development and Validation of the Optimal Circumferential Resection Margin in Pathological T3 Esophageal Cancer: A Multicenter, Retrospective Study Ryoma HanedaHirotoshi KikuchiHiroya Takeuchi Thoracic Oncology 02 March 2022 Pages: 4452 - 4461
ASO Author Reflections: The Optimal Circumferential Resection Margin in Pathological T3 Esophageal Cancer Ryoma HanedaHirotoshi KikuchiHiroya Takeuchi ASO Author Reflections 05 March 2022 Pages: 4462 - 4463
ASO Visual Abstract: Development and Validation of the Optimal Circumferential Resection Margin in Pathological T3 Esophageal Cancer: A Multicenter Retrospective Study Ryoma HanedaHirotoshi KikuchiHiroya Takeuchi ASO Visual Abstract 07 March 2022 Pages: 4464 - 4464
Impact of the Ratio of Visceral Fat Area (VFA) to Psoas Muscle Area (PMA) (V/P Ratio) on Survival for Surgically Resected Esophageal Cancer Makoto SakaiMakoto SohdaHiroshi Saeki Thoracic Oncology 08 March 2022 Pages: 4465 - 4471
ASO Author Reflections: Impact of the Ratio of the Visceral Fat Area (VFA) to Psoas Muscle Area (PMA) (V/P Ratio) on Survival for Patients with Surgically Resected Esophageal Cancer Makoto SakaiMakoto SohdaHiroshi Saeki ASO Author Reflections 19 April 2022 Pages: 4472 - 4473
ASO Visual Abstract: Impact of the Ratio of the Visceral Fat Area (VFA) to Psoas Muscle Area (PMA) (V/P Ratio) on Survival for Surgically Resected Esophageal Cancer Makoto SakaiMakoto SohdaHiroshi Saeki ASO Visual Abstract 30 March 2022 Pages: 4474 - 4475
Fluorescence Imaging-Guided Identification of Thymic Masses Using Low-Dose Indocyanine Green Yu Hua QuanRong XuHyun Koo Kim Thoracic Oncology 09 March 2022 Pages: 4476 - 4485
ASO Visual Abstract: Fluorescence Imaging-Guided Identification of Thymic Masses Using Low-Dose Indocyanine Green Yu Hua QuanRong XuHyun Koo Kim ASO Visual Abstract 23 March 2022 Pages: 4486 - 4487
Exposure to a Postoperative Hypercoagulable State Predicts Poor Prognosis After Transthoracic Esophagectomy in Patients with Esophageal Cancer Junichi SanoSatoru MatsudaYuko Kitagawa Thoracic Oncology 28 March 2022 Pages: 4488 - 4497
ASO Author Reflections: Can We Target a Postoperative Hypercoagulable State in the Acute Phase after Esophagectomy for Esophageal Cancer? Junichi SanoSatoru MatsudaYuko Kitagawa ASO Author Reflections 31 March 2022 Pages: 4498 - 4499
ASO Visual Abstract: Exposure to a Postoperative Hypercoagulable State Predicts Poor Prognosis After Transthoracic Esophagectomy in Patients with Esophageal Cancer Junichi SanoSatoru MatsudaYuko Kitagawa ASO Visual Abstract 02 April 2022 Pages: 4500 - 4501
Body Mass Index-Adjusted Weight Loss Grading System and Cancer-Related Fatigue in Survivors 1 Year After Esophageal Cancer Surgery Zhao ChengPoorna AnandavadivelanPernilla Lagergren Thoracic Oncology Open access 01 April 2022 Pages: 4502 - 4510
ASO Visual Abstract: Body Mass Index-Adjusted Weight-Loss Grading System and Cancer-Related Fatigue in Survivors 1 Year After EsophagealCancer Surgery Zhao ChengPoorna AnandavadivelanPernilla Lagergren ASO Visual Abstract 13 April 2022 Pages: 4511 - 4511
Changes in Perioperative Platelet Lymphocyte Ratio Predict Survival in Oesophago-Gastric Adenocarcinoma James TankelAlexander CalderoneJonathan Cools-Lartigue Thoracic Oncology 04 April 2022 Pages: 4512 - 4519
ASO Visual Abstract: Changes in Perioperative Platelet Lymphocyte Ratio Predict Survival in Esophagogastric Adenocarcinoma James TankelAlexander CalderoneJonathan Cools-Lartigue ASO Visual Abstract 30 April 2022 Pages: 4520 - 4520
Correction to: Fluorescence Imaging-Guided Identification of Thymic Masses Using Low-Dose Indocyanine Green Yu Hua QuanRong XuHyun Koo Kim Correction 18 March 2022 Pages: 4521 - 4521
Functions and Clinical Significance of CACNA2D1 in Gastric Cancer Hiroyuki InoueAtsushi ShiozakiEigo Otsuji Translational Research 20 April 2022 Pages: 4522 - 4535
ASO Author Reflections: CACNA2D1 may have a Potential as a Biomarker for Cancer Growth and as a Therapeutic Target for Gastric Cancer Hiroyuki InoueAtsushi ShiozakiEigo Otsuji ASO Author Reflections 16 April 2022 Pages: 4536 - 4537
ASO Visual Abstract: Functions and Clinical Significance of CACNA2D1 in Gastric Cancer Hiroyuki InoueAtsushi ShiozakiEigo Otsuji ASO Visual Abstract 02 May 2022 Pages: 4538 - 4539
Oxidative Stress Predicts Post-Surgery Complications in Gastrointestinal Cancer Patients M. LeimkühlerA. R. BourgonjeB. L. van Leeuwen Translational Research Open access 17 February 2022 Pages: 4540 - 4547
ASO Author Reflections: Oxidative Stress as a Predictor of Short-Term Outcome After Oncological Surgery for Gastrointestinal Cancer M. LeimkühlerA. R. BourgonjeB. L. van Leeuwen ASO Author Reflections Open access 28 February 2022 Pages: 4548 - 4549
ASO Visual Abstract: Oxidative Stress Predicts Post-surgery Complications in Gastrointestinal Cancer Patients M. LeimkühlerA. R. BourgonjeB. L. van Leeuwen ASO Visual Abstract 16 April 2022 Pages: 4550 - 4551
Predicting Genomic Alterations of Phosphatidylinositol-3 Kinase Signaling in Hepatocellular Carcinoma: A Radiogenomics Study Based on Next-Generation Sequencing and Contrast-Enhanced CT Haotian LiaoHanyu JiangYong Zeng Translational Research 14 March 2022 Pages: 4552 - 4564
ASO Author Reflections: Characterizing the Genomic Alterations in Hepatocellular Carcinoma by Contrast-Enhanced CT Haotian LiaoHanyu JiangYong Zeng ASO Author Reflections 03 March 2022 Pages: 4565 - 4566
ASO Visual Abstract: Predicting Genomic Alterations of Phosphatidylinositol-3 Kinase Signaling in Hepatocellular Carcinoma—A Radiogenomics Study Based on Next-Generation Sequencing and Contrast-Enhanced CT Haotian LiaoHanyu JiangYong Zeng ASO Visual Abstract 20 April 2022 Pages: 4567 - 4567
LKB-1 Expression and High-Risk Histopathology are Independent Prognostic Factors for Patients with Oral Cavity Carcinoma José F. CarrilloChristian Cruz-RomeroLuis F. Oñate-Ocaña Translational Research 23 March 2022 Pages: 4568 - 4578
ASO Author Reflections: The Pursuit of Prognostic Factors to Fine-Tune Treatment Decisions in Patients with Oral Cavity Carcinoma José F. CarrilloAlejandro Avilés-SalasLuis F. Oñate-Ocaña ASO Author Reflections 22 March 2022 Pages: 4579 - 4580
ASO Visual Abstract: The Intensity of LKB-1 Expression, High-Risk Histopathology and TNM Stages are Independent Prognostic Factors in Oral Cavity Carcinoma José F. CarrilloChristian Cruz-RomeroLuis F. Oñate-Ocaña ASO Visual Abstract 04 April 2022 Pages: 4581 - 4582
Phase II Prospective, Open-Label Randomized Controlled Trial Comparing Standard of Care Chemotherapy With and Without Sequential Cytoreductive Interventions for Patients with Oligometastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor Deoxyribose Nucleic Acid (ctDNA) Levels Ankit DhimanCharles C. ViningKiran K. Turaga Gastrointestinal Oncology 05 January 2022 Pages: 4583 - 4592
ASO Author Reflections: The Utility of Circulating-Tumor DNA in Selecting Patients for Locoregional, Metastases-Directed Therapies in Oligometastatic Foregut Adenocarcinoma Ankit DhimanHunter D. D. WitmerKiran K. Turaga ASO Author Reflections 16 April 2022 Pages: 4593 - 4594
Preoperative Muscle-Adipose Index: A New Prognostic Factor for Gastric Cancer Jun LuZhen XueChao-Hui Zheng Gastrointestinal Oncology 16 March 2022 Pages: 4595 - 4607
ASO Visual Abstract: Preoperative Muscle-Adipose Index—A New Prognostic Factor for Gastric Cancer Jun LuZhen XueChao-Hui Zheng ASO Visual Abstract 03 May 2022 Pages: 4608 - 4609
Is There a Benefit to Adjuvant Chemotherapy in Resected, Early Stage Pancreatic Ductal Adenocarcinoma? Kevin M. TurnerAaron M. DelmanSameer H. Patel Pancreatic Tumors 31 March 2022 Pages: 4610 - 4619
ASO Author Reflections: The Survival Advantage Persists: Benefit of Adjuvant Chemotherapy in Resected, Stage IA Pancreatic Cancer Kevin M. TurnerSameer H. Patel ASO Author Reflections 30 March 2022 Pages: 4620 - 4621
ASO Visual Abstract: Is There a Benefit to Adjuvant Chemotherapy in Resected, Early-Stage Pancreatic Ductal Adenocarcinoma? Kevin M. TurnerAaron M. DelmanSameer H. Patel ASO Visual Abstract 06 April 2022 Pages: 4622 - 4623
Prediction of Recurrence Pattern of Pancreatic Cancer Post-Pancreatic Surgery Using Histology-Based Supervised Machine Learning Algorithms: A Single-Center Retrospective Study Koki HayashiYoshihiro OnoYu Takahashi Pancreatic Tumors 01 March 2022 Pages: 4624 - 4634
ASO Author Reflections: Histology-Based Supervised Machine Learning Model Can Predict Recurrence Pattern of Pancreatic Cancer Koki HayashiYoshihiro OnoYu Takahashi ASO Author Reflections 12 March 2022 Pages: 4635 - 4636
ASO Visual Abstract: Prediction of Recurrence Pattern of Pancreatic Cancer Post-Pancreatic Surgery Using Histology-Based Supervised Machine Learning Algorithms–A Single-Center, Retrospective Study Koki HayashiYoshihiro OnoYu Takahashi ASO Visual Abstract 09 April 2022 Pages: 4637 - 4638
Comment on: “Impact of Tumor Size on the Outcomes of Patients with Resectable Distal Pancreatic Cancer” D. Brock HewittHassan AzizTimothy M. Pawlik Pancreatic Tumors 30 April 2022 Pages: 4639 - 4640
Response: Impact of Tumor Size on Outcomes for Patients with Resectable Distal Pancreatic Cancer Genki WatanabeHiromichi Ito Pancreatic Tumors 10 May 2022 Pages: 4641 - 4642
Resection Margins Assessment by Intraoperative Flow Cytometry in Pancreatic Cancer Georgios S. MarkopoulosAnna GoussiaGeorge Vartholomatos Pancreatic Tumors 18 March 2022 Pages: 4643 - 4645
Landmark Series: Importance of Pancreatic Resection Margins Response to Comments to the Editor—Resection Margins Assessment by Intraoperative Flow Cytometry in Pancreatic Cancer Mihir M. ShahDavid A. Kooby Pancreatic Tumors 03 April 2022 Pages: 4646 - 4646
The Role of Diffusion-Weighted Magnetic Resonance Imaging in Staging after Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Adenocarcinoma Edoardo Maria MuttilloEmanuele Felli Pancreatic Tumors 11 April 2022 Pages: 4647 - 4648
The Role of Diffusion-Weighted Magnetic Resonance Imaging in Staging After Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Adenocarcinoma: Reply Alex B. BlairGeorgios GemenetzisJin He Pancreatic Tumors 18 April 2022 Pages: 4649 - 4650
Comment on “Surgery for Intraductal Papillary Mucinous Neoplasms of the Pancreas: Preoperative Factors Tipping the Scale of Decision-Making” Zhenlu LiMao LiHuimin Lu Pancreatic Tumors Open access 12 April 2022 Pages: 4651 - 4652
Response to the Comment on: “Surgery for Intraductal Papillary Mucinous Neoplasms of the Pancreas: Preoperative Factors Tipping the Scale of Decision-Making” Giampaolo PerriGiovanni MarchegianiRoberto Salvia Pancreatic Tumors 12 April 2022 Pages: 4653 - 4653